CRVS

Conviction 32HealthcareScan · Thu, Sep 24, 2026

Corvus Pharmaceuticals, Inc. (CRVS) closed at $11.82 (-5.78%) on Sep 24, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 36, RS Rating 93, -53.7% from its 52-week high, +61.4% year to date. Sector: Healthcare · PHARMACEUTICAL PREPARATIONS.

CRVS$11.82-5.78%

ResistanceSupportVol 14Insider buy

Vol MA14 1.41M

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

Corvus Pharmaceuticals, Inc.PHARMACEUTICAL PREPARATIONSwww.corvuspharma.com ↗

Price11.82

Change-5.78%

Gap+0.32%

Rel volume2.21×

Avg volume1.19M

Avg $ vol15.46M

SMA 2013.36

SMA 5013.82

SMA 20014.07

Price vs 50-14.53%

Price vs 200-16.00%

MA stackbearish

50/200 crossdeath · 3d

Supertrenddown · 14.34

RSI (14)36

MACD hist-0.11

MACD cross—

Stoch %K / %D10 / 24

ADX (14)17

+DI / −DI16 / 27

RSI divergence—

MACD divergence—

ATR %6.31%

ADR %5.06%

52w high25.52

52w low6.48

From 52w high-53.70%

Above 52w low+82.33%

New 52w highNo

SqueezeOff

Bollinger width25.64%

%B0.05

Donchian pos8.53%

Donchian high15.14

Donchian low11.51

AVWAP (52w high)15.54

vs AVWAP high-23.98%

AVWAP (52w low)14.84

vs AVWAP low-20.37%

OBV trendDown

Chaikin MF (20)-0.02

Today vs 20d2.21×

Avg vol (14d)1.41M

Avg vol (20d)1.19M

Avg $ vol (20d)15.46M

Market cap993.89M

RS Rating93 / 99

RS 3m (vs SPY)-13.95%

RS 6m (vs SPY)-33.73%

RS line new highNo

Trend template3/8

Technical rank16.3

1 week-5.86%

1 month-18.85%

3 months-9.46%

6 months-16.91%

1 year+93.06%

YTD+61.41%

P/E-65.03

P/B4.41

P/S—

P/FCF-30.14

EPS-0.5300

Div yield—

ROE-6.78%

ROA-6.39%

Debt/Eq—

Current16.16

EV/EBITDA-22.74

Gross margin—

Net margin—

Rev growth—

EPS growth75.47%

Price target29.50

Target upside149.68%

Analyst ratingBuy

Institutional88.70%

Ent. value974.98M

Revenue—

Net income-17.96M

Gross profit—

Free cash flow-32.97M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out84.09M

Employees37

ListedWed, Mar 23, 2016

Free float58.06M

Float %69.3%

Short interest19.02M

Days to cover29.6d

Short volume61.3%

Squeeze score94 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.19 vs −$0.17

Last surprise-11.8% miss

Setup gradeD

Conviction32 / 100

Pattern quality—

Tech rank16.3 / 100

Group rank59 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance15.58

Support12.49

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in CRVS

All disclosures →

No recent disclosed trades by Congress in CRVS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CRVS · open-market 2 buys

Insider	Side	Shares	Value	Traded	Filed
MILLER RICHARD A MD President and CEO · Common Stock · 2026-05-18	Buy	5K	$60K	2026-05-18	2026-05-20
MILLER RICHARD A MD President and CEO · Common Stock · 2026-05-18	Buy	1.93K	$23K	2026-05-18	2026-05-20
MILLER RICHARD A MD President and CEO · Common Stock · 2026-05-18	Other	—	—	2026-05-18	2026-05-20
Chan Andrew C. Director · Stock Option (Right to Buy) · 2026-04-23	Grant	30K	$0	2026-04-23	2026-04-27

SEC filings

EDGAR filings in CRVS · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.